Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Esteem Stuffed Gaming Workstations to Consider - 2January full moon wows skywatchers with a striking 'Wolf Supermoon' (photos)
- 3Wizz CEO: We’re going to invest $1 b. in Israeli market
- 4KJ Apa stars as Jimmy Stewart in new biopic: See his transformation
- 5Step by step instructions to Analyze Senior Insurance Contracts Really.
- My Excursion to a Better Way of life: Health Experiences
- Video Conferencing Instruments for Virtual Gatherings
- Bondi Beach survivor criticizes police for inaction during terror attack
- The Most Notable Design Brands of the 21st Hundred years
- Find Wonderful Stream Voyage Objections On the planet
- The most effective method to Examine a Cellular breakdown in the lungs Finding with Family
- Astronomers discover never-before-seen celestial object: "Cloud 9"
- Bad flu season getting worse; skyrocketing cases set state record
- Christopher Nolan's 'The Odyssey' trailer: See Anne Hathaway, Matt Damon and Tom Holland in 1st look at movie
